Home › NDC Lookup › RxCUI directory › RxCUI 309077

Cefpodoxime 20 MG/ML Oral Suspension — RxCUI 309077

RxNorm drug concept · Semantic clinical drug
RxCUI 309077 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI309077
Official nameCefpodoxime 20 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascefpodoxime 100 MG per 5 ML Oral Suspension; cefpodoxime 100 MG in 5 mL Oral Suspension; cefpodoxime (as cefpodoxime proxetil) 100 MG per 5 ML Oral Suspension
FDA products mapped6
Package NDCs mapped14
Reported Medicaid activity (SDUD)3,613 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cefpodoxime: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Cefpodoxime treats a wide range of common bacterial infections. These include ear infections, strep throat and tonsillitis, sinus infections, pneumonia, bronchitis flare-ups, skin...
  • What kinds of infections does cefpodoxime treat?
  • It depends on which form you have. If you're taking the tablet, take it with food — your body absorbs it better that way, so you'll get more of the medication working for you. If y...
  • Should I take cefpodoxime with food or on an empty stomach?
📖 Read our full Cefpodoxime guide →

🕸️ Concept Web — How Cefpodoxime 20 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cefpodoxime 20 MG/ML Oral Suspension RxCUI 309077

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cefpodoxime 20489
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cefpodoxime Oral Suspension 371333
    • Cefpodoxime Oral Liquid Product 1160611
    • Cefpodoxime Oral Product 1161214
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cefpodoxime 20 MG/ML 330672

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cefpodoxime 20 MG/ML SCDC · 330672
  • Cefpodoxime Oral Suspension SCDF · 371333
  • Cefpodoxime Oral Liquid Product SCDG · 1160611
  • Cefpodoxime Oral Product SCDG · 1161214

📦 FDA Products & Package NDCs

6 products · 14 package NDCs
14 package NDCs map to RxCUI 309077 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
16714-0402-01 1 BOTTLE in 1 CARTON (16714-402-01) / 50 mL in 1 BOTTLE Cefpodoxime Proxetil NorthStar Rx LLC 2007-06-08
16714-0402-02 1 BOTTLE in 1 CARTON (16714-402-02) / 100 mL in 1 BOTTLE Cefpodoxime Proxetil NorthStar Rx LLC 2007-06-08
16714-0403-01 1 BOTTLE in 1 CARTON (16714-403-01) / 50 mL in 1 BOTTLE Cefpodoxime Proxetil NorthStar Rx LLC 2007-06-08
16714-0403-02 1 BOTTLE in 1 CARTON (16714-403-02) / 100 mL in 1 BOTTLE Cefpodoxime Proxetil NorthStar Rx LLC 2007-06-08
64980-0402-10 1 BOTTLE in 1 CARTON (64980-402-10) / 100 mL in 1 BOTTLE Cefpodoxime Proxetil Rising Pharma Holdings, Inc. 2007-06-08
64980-0402-50 1 BOTTLE in 1 CARTON (64980-402-50) / 50 mL in 1 BOTTLE Cefpodoxime Proxetil Rising Pharma Holdings, Inc. 2007-06-08
64980-0403-10 1 BOTTLE in 1 CARTON (64980-403-10) / 100 mL in 1 BOTTLE Cefpodoxime Proxetil Rising Pharma Holdings, Inc. 2007-06-08
64980-0403-50 1 BOTTLE in 1 CARTON (64980-403-50) / 50 mL in 1 BOTTLE Cefpodoxime Proxetil Rising Pharma Holdings, Inc. 2007-06-08
65862-0140-01 1 BOTTLE in 1 CARTON (65862-140-01) / 100 mL in 1 BOTTLE Cefpodoxime Proxetil Aurobindo Pharma Limited 2007-06-08
65862-0140-50 1 BOTTLE in 1 CARTON (65862-140-50) / 50 mL in 1 BOTTLE Cefpodoxime Proxetil Aurobindo Pharma Limited 2007-06-08
65862-0140-75 1 BOTTLE in 1 CARTON (65862-140-75) / 75 mL in 1 BOTTLE Cefpodoxime Proxetil Aurobindo Pharma Limited 2007-06-08
65862-0141-01 1 BOTTLE in 1 CARTON (65862-141-01) / 100 mL in 1 BOTTLE Cefpodoxime Proxetil Aurobindo Pharma Limited 2007-06-08
65862-0141-50 1 BOTTLE in 1 CARTON (65862-141-50) / 50 mL in 1 BOTTLE Cefpodoxime Proxetil Aurobindo Pharma Limited 2007-06-08
65862-0141-75 1 BOTTLE in 1 CARTON (65862-141-75) / 75 mL in 1 BOTTLE Cefpodoxime Proxetil Aurobindo Pharma Limited 2007-06-08
Observed labelers: Aurobindo Pharma Limited (6) · NorthStar Rx LLC (4) · Rising Pharma Holdings, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.